SCHEMBL28894077

SCHEMBL28894077

Cc1ccc(-c2ccn(S(=O)(=O)N(C)C)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.40
SMN1; SMN2 Q16637 6/20 0.40
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
HTT P42858 1/20 0.40
CYP2C9 P11712 3/20 0.39
GAA P10253 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
TP53 P04637 1/20 0.37
PTGS2 P35354 1/20 0.36
NPY5R Q15761 3/20 0.36
ALDH1A1 P00352 2/20 0.35
KEAP1 Q14145 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 2/20 0.35
STAT1 P42224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28894119 0.85 KMT2A (0.50) MAPTSMN1; SMN2MEN1KMT2ACYP2C9
SCHEMBL23951418 0.81 KMT2A (0.44) MAPTSMN1; SMN2MEN1KMT2ACYP2C9
SCHEMBL23951524 0.80 GAA (0.47) MAPTSMN1; SMN2MEN1KMT2AHTT
SCHEMBL12128393 0.75 HTT (0.47) MAPTSMN1; SMN2MEN1KMT2AHTT
SCHEMBL2049442 0.72 MEN1 (0.55) SMN1; SMN2MEN1KMT2ATSHRLMNA
SCHEMBL23649472 0.71 GAA (0.66) MAPTSMN1; SMN2MEN1KMT2AHTT
SCHEMBL31598915 0.71 MEN1 (0.46) MAPTSMN1; SMN2MEN1KMT2AHTT
SCHEMBL25360339 0.70 MEN1 (0.37) SMN1; SMN2MEN1KMT2AHTTGAA
SCHEMBL959784 0.70 MEN1 (0.37) SMN1; SMN2MEN1KMT2AHTTGAA
SCHEMBL535681 0.70 HTT (0.36) SMN1; SMN2MEN1KMT2AHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115209952-A Substituted pyrazolopyrimidines and use thereof 维基分析有限公司 2022-10-18 CN disclosed